Respiratory
Pathogens Panel

  • Bordetella Parapertussis

  • Bordetella pertussis

  • Coronavirus HKU 1 

  • Coronavirus NL63 

  • Coronavirus 229E 

  • Coronavirus 0C43 

  • Entrovirus

  • Haemophilus Influenza Type B

  • Human Metapneumovirus

  • Human Bocavirus

  • Human Rhinovirus/Enterovirus 

  • Influenza A 

  • Influenza B

  • Pan-Adenovirus

  • Respiratory Syncytial Virus A & B

  • SARS-CoV-2 N1

  • SARS-CoV-2 N2

  • Human Parainfluenza Virus 1

  • Human Parainfluenza Virus 2 

  • Human Parainfluenza Virus 3 

  • Human Parainfluenza Virus 4

  • MRSA (mecA, mecC, Class B mec

  • Staphylococcus aures

  • Streptococcus pyogenes 

  • Moraxella Catarrhalis

  • Mycoplasma pneumonia

  • Streptococcus pneumoniae

  • Haemophilus Influenza

  • Klebsiella pneumoniae

  • Chlamydia pneumonia

  • Legionella pneumoniae

Antibiotic Stewardship Quick Facts

  • Each year in the US, 2 million people acquire serious bacterial infections that are resistant to one or more prescribed antibiotics, and at least 23,000 people die as a direct result of these antibiotic-resistant infections.8 

  • An estimated 55% of antibiotic prescriptions for Acute Respiratory Tract Infections are unnecessary.’ 

  • The misuse of antibiotics costs the US healthcare system over $20 billion each year.’° 

Implications of Antibiotic Resistance

  • Increases mortality and morbidity from untreatable diseases. 

  • Increases risk of global spread of pathogens. 

  • Results in longer, more frequent hospital stays. 

  • Limits drug options at a time when pharmaceutical companies are developing fewer new antimicrobials.

  • Increases cost of research for new drugs.